ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

GSK GSK plc

43.58
0.23 (0.53%)
04 May 2024 - Closed
Delayed by 15 minutes
Name Symbol Market Type
GSK plc NYSE:GSK NYSE Depository Receipt
  Price Change % Change Price High Price Low Price Open Price Traded Last Trade
  0.23 0.53% 43.58 43.68 43.27 43.58 4,048,068 01:00:00

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

10/11/2022 11:25am

Edgar (US Regulatory)


 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
 
 
For the month of November 2022
 
Commission File Number 001-15170
 
 
GSK plc
(Translation of registrant's name into English)
 
 
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive office)
 
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F . . . .X. . . . Form 40-F . . . . . . . .
 
 
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
 
 
 
 
GSK plc
 
Block listing Application
 
 
Application has been made to the Financial Conduct Authority and the London Stock Exchange plc for a total of 1,400,000 Ordinary Shares of 31¼p each ('Shares') to be admitted to the Official List.
 
The Shares are being reserved under a block listing and will be issued under the GlaxoSmithKline plc Share Save Plan 2022 and GlaxoSmithKline plc 2017 Deferred Annual Bonus Plan.
 
When issued, the Shares will rank pari passu with the existing Ordinary Shares of 31¼p each.
 
Admission is expected to be effective on 11 November 2022.
 
 
 
 
V A Whyte
Company Secretary
 
10 November 2022
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.
 
GSK plc
 
(Registrant)
 
 
Date: November 10, 2022
 
 
 
 
By:/s/ VICTORIA WHYTE
--------------------------
 
 
 
Victoria Whyte
 
Authorised Signatory for and on
 
behalf of GSK plc
 

1 Year GSK Chart

1 Year GSK Chart

1 Month GSK Chart

1 Month GSK Chart

Your Recent History

Delayed Upgrade Clock